Q BioMed Files for Orphan Drug Designation with U.S. FDA for Autism Spectrum Disorder Subtype
June 28, 2019 08:32 ET
|
Q BioMed Inc.
Currently no effective treatment exists for the 20,000 children in the U.S. and 250,000 born worldwide each year with pediatric minimally verbal autism (PMVA) NEW YORK, June 28, 2019 (GLOBE...